Taken together, these findings support the hypothesis that p300/CBP directly regulates FLT3 transcription by facilitating H3K27Ac recruitment to its promoter region, thereby accounting for the sensitivity of AML cells to p300/CBP inhibitors. The gene discussed is FLT3; the disease is acute myeloid leukemia.